E-ISSN 2277-338X
 

Original Research
Online Published: 03 May 2016
 


Can cyclin D1 be utilized as a second step “after basal cell marker” for both diagnosis and prognosis of prostatic adenocarcinoma?

.


Abstract
No abstract available


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

. Can cyclin D1 be utilized as a second step “after basal cell marker” for both diagnosis and prognosis of prostatic adenocarcinoma?. Int J Med Sci Public Health. 2016; 5(5): 886-893. doi:10.5455/ijmsph.2016.28122015311


Web Style

. Can cyclin D1 be utilized as a second step “after basal cell marker” for both diagnosis and prognosis of prostatic adenocarcinoma?. https://www.ijmsph.org/?mno=214170 [Access: June 27, 2026]. doi:10.5455/ijmsph.2016.28122015311


AMA (American Medical Association) Style

. Can cyclin D1 be utilized as a second step “after basal cell marker” for both diagnosis and prognosis of prostatic adenocarcinoma?. Int J Med Sci Public Health. 2016; 5(5): 886-893. doi:10.5455/ijmsph.2016.28122015311



Vancouver/ICMJE Style

. Can cyclin D1 be utilized as a second step “after basal cell marker” for both diagnosis and prognosis of prostatic adenocarcinoma?. Int J Med Sci Public Health. (2016), [cited June 27, 2026]; 5(5): 886-893. doi:10.5455/ijmsph.2016.28122015311



Harvard Style

(2016) Can cyclin D1 be utilized as a second step “after basal cell marker” for both diagnosis and prognosis of prostatic adenocarcinoma?. Int J Med Sci Public Health, 5 (5), 886-893. doi:10.5455/ijmsph.2016.28122015311



Turabian Style

. 2016. Can cyclin D1 be utilized as a second step “after basal cell marker” for both diagnosis and prognosis of prostatic adenocarcinoma?. International Journal of Medical Science and Public Health, 5 (5), 886-893. doi:10.5455/ijmsph.2016.28122015311



Chicago Style

. "Can cyclin D1 be utilized as a second step “after basal cell marker” for both diagnosis and prognosis of prostatic adenocarcinoma?." International Journal of Medical Science and Public Health 5 (2016), 886-893. doi:10.5455/ijmsph.2016.28122015311



MLA (The Modern Language Association) Style

. "Can cyclin D1 be utilized as a second step “after basal cell marker” for both diagnosis and prognosis of prostatic adenocarcinoma?." International Journal of Medical Science and Public Health 5.5 (2016), 886-893. Print. doi:10.5455/ijmsph.2016.28122015311



APA (American Psychological Association) Style

(2016) Can cyclin D1 be utilized as a second step “after basal cell marker” for both diagnosis and prognosis of prostatic adenocarcinoma?. International Journal of Medical Science and Public Health, 5 (5), 886-893. doi:10.5455/ijmsph.2016.28122015311